BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 513974)

  • 1. Morphine- and opioid peptide-induced inhibition of the release of dopamine from tuberoinfundibular neurons.
    Gudelsky GA; Porter JC
    Life Sci; 1979 Nov; 25(19):1697-702. PubMed ID: 513974
    [No Abstract]   [Full Text] [Related]  

  • 2. Current Review of the Function and Regulation of Tuberoinfundibular Dopamine Neurons.
    Qi-Lytle X; Sayers S; Wagner EJ
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of prolactin in mice with altered hypothalamic melanocortin activity.
    Dutia R; Kim AJ; Mosharov E; Savontaus E; Chua SC; Wardlaw SL
    Peptides; 2012 Sep; 37(1):6-12. PubMed ID: 22800691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs and prolactin.
    Molitch ME
    Pituitary; 2008; 11(2):209-18. PubMed ID: 18404390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of opioid antagonism on prolactin secretion and c-Fos/TH expression during lactation in rats.
    Zhang B; Hou Y; Voogt JL
    Endocrine; 2004 Nov; 25(2):131-6. PubMed ID: 15711026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of naloxone infusion on nocturnal prolactin secretion and Fos/FRA expression in pregnant rats.
    Hou Y; Voogt JL
    Endocrine; 1999 Apr; 10(2):145-52. PubMed ID: 10451223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hormonal response to stress is not modified by the dramatic decrease in prolactin plasma concentration during surgery for microprolactinoma.
    Guieu R; Dufour H; Devaux C; Brue T; Rosso JP; Grisoli F; Grino M; Enjalbert A; Begoud D; Broder N; Rochat H; Jaquet P
    J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):502-7. PubMed ID: 9771773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine differentially alters synthesis and turnover of dopamine in central neuronal systems.
    Alper RH; Demarest KT; Moore KE
    J Neural Transm; 1980; 48(3):157-65. PubMed ID: 6772740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermorphin, a new opioid peptide, stimulates thyrotropin secretion in normal subjects.
    Roti E; Degli Uberti E; Salvadori S; Bianconi M; Emanuele R; Rotola C; Trasforini G; Robuschi G; Tomatis R; Gnudi A
    J Endocrinol Invest; 1984 Jun; 7(3):211-4. PubMed ID: 6470436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin, amitriptyline, and recovery from depression.
    Lisansky J; Fava GA; Buckman MT; Kellner R; Fava M; Zielezny M; Peake GT
    Psychopharmacology (Berl); 1984; 84(3):331-5. PubMed ID: 6440179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methysergide decreases prolactin release after FK 33-824 [Tyr-D-Ala-Gly-MePhe-Met(o)-ol], a potent analogue of methionine enkephalin. A study in man.
    Jungkunz G; Nedopil N; Rüther E
    Psychopharmacology (Berl); 1984; 83(2):210-2. PubMed ID: 6431476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinergic and histaminergic involvement in the growth hormone releasing effect of an enkephalin analog FK 33-824 in man.
    Peñalva A; Villanueva L; Casanueva F; Cavagnini F; Gomez-Pan A; Müller EE
    Psychopharmacology (Berl); 1983; 80(2):120-4. PubMed ID: 6308703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naloxone effects on beta-endorphin, cortisol, prolactin, growth hormone, HVA and MHPG in plasma of normal volunteers.
    Naber D; Pickar D; Davis GC; Cohen RM; Jimerson DC; Elchisak MA; Defraites EG; Kalin NH; Risch SC; Buchsbaum MS
    Psychopharmacology (Berl); 1981; 74(2):125-8. PubMed ID: 6267643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New concepts in the regulation of hypothalamic gonadotropin releasing hormone (GnRH) secretion.
    Rasmussen DD
    J Endocrinol Invest; 1986 Oct; 9(5):427-37. PubMed ID: 3540082
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of methysergide, bromocriptine and naloxone on prolactin, growth hormone and TSH release induced by D-Met2,Pro5-enkephalinamide in man.
    Földes J; Váradi A; Gara A; Bános C; Vargha P; Török K; Székely JI
    Psychopharmacology (Berl); 1986; 88(3):331-5. PubMed ID: 3083453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by naloxone of the rise in hypothalamic dopamine and serum prolactin induced by ethanol.
    Seilicovich A; Rubio M; Duvilanski B; Muñoz Maines V; Rettori V
    Psychopharmacology (Berl); 1985; 87(4):461-3. PubMed ID: 3001809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical study on the relationship between the pineal gland and the opioid system.
    Lissoni P; Esposti D; Esposti G; Mauri R; Resentini M; Morabito F; Fumagalli P; Santagostino A; Delitala G; Fraschini F
    J Neural Transm; 1986; 65(1):63-73. PubMed ID: 2937880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of brain histamine depletion on stimulated prolactin release in rats.
    Netti C; Guidobono F; Sibilia V; Cazzamalli E; Villa I; Pecile A
    Agents Actions; 1989 Apr; 27(1-2):117-9. PubMed ID: 2750583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction between mediobasohypothalamic dopaminergic and endorphinergic neuronal systems as a key regulator of reproduction: an hypothesis.
    Rasmussen DD
    J Endocrinol Invest; 1991 Apr; 14(4):323-52. PubMed ID: 1865083
    [No Abstract]   [Full Text] [Related]  

  • 20. Ontogenic studies of the neural control of adenohypophyseal hormones in the rat. II. Prolactin.
    Becú-Villalobos D; Lacau-Mengido IM; Díaz-Torga GS; Libertun C
    Cell Mol Neurobiol; 1992 Feb; 12(1):1-19. PubMed ID: 1571952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.